Terms: = Breast cancer AND CLTC, CLTCL2, 1213, ENSG00000141367, Q00610 AND Treatment
26 results:
1. Long-term outcome after surgical resection of non-high-risk gastrointestinal stromal tumours without adjuvant therapy.
Berndsen M; Renberg S; Hølmebakk T; Hancke E; Puls F; Karlsson F; Stoldt S; Bjerkehagen B; Haglund de Flon F; Muth A; Papakonstantinou A; Boye K; Lindskog S
Br J Surg; 2023 Nov; 110(12):1857-1862. PubMed ID: 37758514
[TBL] [Abstract] [Full Text] [Related]
2. Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer.
Mistretta B; Rankothgedera S; Castillo M; Rao M; Holloway K; Bhardwaj A; El Noafal M; Albarracin C; El-Zein R; Rezaei H; Su X; Akbani R; Shao XM; Czerniecki BJ; Karchin R; Bedrosian I; Gunaratne PH
Front Immunol; 2023; 14():1188831. PubMed ID: 37744342
[TBL] [Abstract] [Full Text] [Related]
3. Clinical characteristics and survival analysis of Chinese ovarian cancer patients with RAD51D germline mutations.
Yao H; Li N; Yuan H
BMC Cancer; 2022 Dec; 22(1):1337. PubMed ID: 36544182
[TBL] [Abstract] [Full Text] [Related]
4. An evaluation of the readability and visual appearance of online patient resources for fibroadenoma.
Hutchings HA; Remesh A
PLoS One; 2022; 17(11):e0277823. PubMed ID: 36399450
[TBL] [Abstract] [Full Text] [Related]
5. Effectiveness and safety of pegylated liposomal doxorubicin versus epirubicin as neoadjuvant or adjuvant chemotherapy for breast cancer: a real-world study.
Zhang J; Jiang H; Zhang J; Bao G; Zhang G; Wang H; Wang X
BMC Cancer; 2021 Dec; 21(1):1301. PubMed ID: 34872507
[TBL] [Abstract] [Full Text] [Related]
6. Genetic Variability of Antioxidative Mechanisms and Cardiotoxicity after Adjuvant Radiotherapy in HER2-Positive breast cancer Patients.
Marinko T; Stojanov Konda JT; Dolžan V; Goričar K
Dis Markers; 2020; 2020():6645588. PubMed ID: 33425072
[TBL] [Abstract] [Full Text] [Related]
7. Deciphering the vascular labyrinth: role of microRNAs and candidate gene SNPs in brain AVM development - literature review.
Florian IA; Timiș TL; Ungureanu G; Florian IS; Bălașa A; Berindan-Neagoe I
Neurol Res; 2020 Dec; 42(12):1043-1054. PubMed ID: 32723034
[No Abstract] [Full Text] [Related]
8. Combining Adjuvant Radiotherapy With Capecitabine in Chemotherapy-resistant breast cancer: Feasibility, Safety, and Toxicity.
Sherry AD; Mayer IA; Ayala-Peacock DN; Abramson VG; Rexer BN; Chakravarthy AB
Clin Breast Cancer; 2020 Aug; 20(4):344-352.e1. PubMed ID: 32234364
[TBL] [Abstract] [Full Text] [Related]
9. Effectiveness of CO
Angioli R; Stefano S; Filippini M; Pieralli A; Montera R; Plotti F; Gatti A; Bartolone M; Luvero D
Int J Gynecol Cancer; 2020 May; 30(5):590-595. PubMed ID: 32221022
[TBL] [Abstract] [Full Text] [Related]
10. Global variation in the long-term outcomes of ypT0 rectal cancers.
Lorenzon L; Evrard S; Beets G; Gonzalez-Moreno S; Kovacs T; D'Ugo D; Polom K;
Eur J Surg Oncol; 2020 Mar; 46(3):420-428. PubMed ID: 31733929
[TBL] [Abstract] [Full Text] [Related]
11. Germline
de Jonge MM; Ritterhouse LL; de Kroon CD; Vreeswijk MPG; Segal JP; Puranik R; Hollema H; Rookus MA; van Asperen CJ; van Leeuwen FE; Smit VTHBM; Howitt BE; Bosse T;
Clin Cancer Res; 2019 Dec; 25(24):7517-7526. PubMed ID: 31492746
[TBL] [Abstract] [Full Text] [Related]
12. E-cadherin clone 36 nuclear staining dictates adverse disease outcome in lobular breast cancer patients.
Lobo J; Petronilho S; Newell AH; Coach J; Harlow G; Cruz A; Lopes P; Antunes L; Bai I; Walker E; Henrique R
Mod Pathol; 2019 Nov; 32(11):1574-1586. PubMed ID: 31231125
[TBL] [Abstract] [Full Text] [Related]
13. Chemical constituents of Patrinia heterophylla Bunge and selective cytotoxicity against six human tumor cells.
Sheng L; Yang Y; Zhang Y; Li N
J Ethnopharmacol; 2019 May; 236():129-135. PubMed ID: 30853646
[TBL] [Abstract] [Full Text] [Related]
14. [Retrospective analysis of diagnosis and treatment of breast cancer in pregnancy].
Wang FW; Fu SM; Jin YC; Gong XH; Cheng HD; Wu KJ
Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):114-118. PubMed ID: 29397624
[No Abstract] [Full Text] [Related]
15. Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer.
Dodson A; Okonji D; Assersohn L; Rigg A; Sheri A; Turner N; Smith I; Parton M; Dowsett M
Breast Cancer Res Treat; 2018 Feb; 168(1):249-258. PubMed ID: 29128896
[TBL] [Abstract] [Full Text] [Related]
16. Adherence to Adjuvant Endocrine Therapy in Christchurch Women with Early breast cancer.
Robinson B; Dijkstra B; Davey V; Tomlinson S; Frampton C
Clin Oncol (R Coll Radiol); 2018 Jan; 30(1):e9-e15. PubMed ID: 29103853
[TBL] [Abstract] [Full Text] [Related]
17. Outcomes of Triple-Negative breast cancers (TNBC) Compared with Non-TNBC: Does the Survival Vary for All Stages?
Agarwal G; Nanda G; Lal P; Mishra A; Agarwal A; Agrawal V; Krishnani N
World J Surg; 2016 Jun; 40(6):1362-72. PubMed ID: 26842691
[TBL] [Abstract] [Full Text] [Related]
18. The radiological excision of high risk and malignant lesions using the INTACT breast lesion excision system. A case series with an imaging follow up of at least 5 years.
Allen SD; Osin P; Nerurkar A
Eur J Surg Oncol; 2014 Jul; 40(7):824-9. PubMed ID: 24742589
[TBL] [Abstract] [Full Text] [Related]
19. Do breast cups improve breast cancer dosimetry? A comparative study for patients with large or pendulous breasts.
Arenas M; Hernández V; Farrús B; Müller K; Gascón M; Pardo A; Berenguer R; Sabater S
Acta Oncol; 2014 Jun; 53(6):795-801. PubMed ID: 24655017
[TBL] [Abstract] [Full Text] [Related]
20. Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial.
Kenemans P; Bundred NJ; Foidart JM; Kubista E; von Schoultz B; Sismondi P; Vassilopoulou-Sellin R; Yip CH; Egberts J; Mol-Arts M; Mulder R; van Os S; Beckmann MW;
Lancet Oncol; 2009 Feb; 10(2):135-46. PubMed ID: 19167925
[TBL] [Abstract] [Full Text] [Related]
[Next]
